首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1397164

全球手术敷料市场：洞察、竞争格局、市场预测：2028 年

Surgical Dressing - Market Insights, Competitive Landscape, and Market Forecast - 2028

出版日期: 2023年12月18日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 1-3个工作天内

价格

简介目录图表

预计 2023 年至 2028 年预测期内，全球手术敷料市场规模将以 5.72% 的复合年增长率扩大。对手术敷料的需求主要是由于慢性伤口、深度伤口、烧伤、溃疡和其他需要手术治疗的病症的盛行率不断增加而推动的。此外，由于慢性病、事故、创伤等盛行率的增加而导致的外科手术的增加也可能加速对外科敷料的需求。此外，器官移植数量的增加、老年人口的增加、膝关节和髋关节置换手术数量的增加、产品开发的创新等将有助于2023-2028年预测期间整体手术敷料市场的成长。

例如，根据 OECD 2023 年提供的数据，2022 年 8 月，葡萄牙进行了约 94,870 例手术，其次是丹麦 49,330 例、爱尔兰 32,840 例和挪威 32,840 例。2021 年进行了 21,500 例手术。

据同一消息来源称，2021 年，英国进行了近 13,550 例冠状动脉绕道手术，土耳其进行了 45,432 例。

根据棕榈滩个人化骨科的最新研究，光是在美国每年就进行约 80 万次手术，而且这个数字每年都在增加。

根据美国国家家庭健康调查（NFHS）的最新报告，印度剖腹产的趋势呈上升趋势。 2005-2006年为8.5%，2015-2016年增至17.2%，2019-2021年为21.5%。

随着全球外科手术数量的不断增加，手术期间用于保护伤口、预防感染以及促进癒合的手术敷料的需求量预计将增加。因此，外科手术的增加预计将在未来几年推动整个外科敷料市场。

本报告考察了全球手术敷料市场，并提供了市场概况，包括按产品类型、应用、最终用户、地区以及参与市场的公司概况划分的趋势。Masu。

3M
Coloplast
Molnlycke Health Care AB
Cardinal Health
Convatec Inc.
Smith+Nephew
Argentum Medical
Medline Industries, LP.
Advancis Medical
Medical Devices Business Services, Inc.
B. Braun SE
Integra LifeSciences
Medtronic
Essity
Organogenesis Inc.
Medicare
Alliqua
Advanced Medical Solutions Group plc
Hollister Incorporated
deroyal industries

第8章KOL浏览量

第 9 章专案方法

第10章DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0673

Surgical Dressings Market Product Type (Primary Dressings [Film Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Foam Dressings, And Others] And Secondary Dressings [Absorbents, Bandages, Adhesive Tapes, Protectives, And Others]), By Application (Ulcers, Burns, Organ Transplants, Cardiovascular Diseases, And Others), by end-users (hospitals & clinics, ambulatory surgical centers, and others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing number of surgical procedures and innovations in product development.

The global surgical dressings market is estimated to grow at a CAGR of 5.72% during the forecast period from 2023 to 2028. The demand for surgical dressings is primarily being boosted by the increasing prevalence of chronic wounds, deep injuries, burns, ulcers, and other conditions requiring surgical treatment. Moreover, rising surgical procedures owing to the increasing prevalence of chronic diseases, accidents, traumas, and others will also accelerate the demand for surgical dressings. In addition, the increasing cases of organ transplant, the growing elderly population, the number of knee and hip replacement surgeries, and innovation in product development among others, thereby contributing to the overall growth of the surgical dressings market during the forecast period from 2023-2028.

Surgical Dressings Market Dynamics:

For instance, as per the data provided by OECD 2023, in August 2022, about 94.87 thousand surgeries were performed in Portugal, followed by 49.33 thousand in Denmark, 32.84 thousand in Ireland, and 21.5 thousand in Norway in 2021.

As per the same source, nearly 13,550 coronary artery bypass graft surgery was performed in the United Kingdom, and 45,432 in Turkiye in 2021.

The Personalized Orthopedics of the Palm Beaches in a latest study stated that about 800,000 times annually in the United States alone, and that figure increases every year.

As per National Family Health Survey (NFHS) latest reports, the trend of C-section deliveries in India has been on the rise. It was 8.5 percent in 2005-06, 17.2 percent in 2015-16, and in 2019-21, it increased to 21.5 percent.

The growing number of surgical procedures across the globe is anticipated to fuel the demand for surgical dressing during surgery as they are used to protect a wound and prevent infection, but also allow healing. Thus, the growing number of surgical procedures will propel the overall market of surgical dressings in the upcoming years.

Further, the increasing cases of burns, ulcers, traumas, and others will also increase the demand for surgical dressings as non-adherent films or fine mesh gauze are common dressings used to cover the burn wound and ulcers. As per the latest data presented by the NHS United Kingdom, about 700,000 people are affected by pressure ulcers each year. Also, American Burn Association in February 2021, more than 400,000 people receive burn injury treatment every year in the United States. Therefore, the above-mentioned factors will propel the surgical dressings market during the forecast period from 2023-2028.

However, the lack of adequate reimbursement policies, stringent regulatory approval processes, and others may restrict the growth of the overall surgical dressings market.

Surgical Dressings Market Segment Analysis:

Surgical Dressings Market by Product Type (Primary Dressings [Film Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Foam Dressings, and Others] and Secondary Dressings [Absorbents, Bandages, Adhesive Tapes, Protectives, and Others]), By Application (Ulcers, Burns, Organ Transplants, Cardiovascular Diseases, and Others), By End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the surgical dressings market, the foam dressing category is expected to amass a significant revenue share in the year 2022. This can be ascribed to the advantages and applications associated with the segment.

The foam dressings are effective at alleviating the discomfort and pain associated with weeping wounds or dressing-related damage. Foam dressings are available in various sizes and shapes. Some have adhesive tape, or borders, around the edges for easier application.

These dressings are used in case of leg ulcers, skin grafts, minor burns, abrasions, lacerations, and injuries in need of negative pressure therapy. The foam dressings offer both cushioning and flexibility, so they can be used under compression wraps and cut to accommodate tubing for procedures like tracheostomy and gastrostomy.

The dressing serves as a bacterial barrier and helps prevent hyper-granulation. It is flexible enough to adhere to body parts like toes, fingers, or ears. The dressing is perfect for bony protrusions and areas of the skin that are more likely to be agitated.

Further, increasing product launches, approvals, and other strategic activities will also propel the demand for foam dressings in the upcoming years. For instance, In November 2020, Advanced Medical Solutions Group plc, the surgical and advanced wound care specialist company, received CE mark approval for the Group's Silicone PHMB Foam Dressing.

Therefore, owing to the above-mentioned factors, the foam dressings category is expected to register significant growth, thereby driving the growth of the overall surgical dressings market during the forecast period.

North America is expected to dominate the overall Surgical Dressings Market:

Among all the regions, North America is estimated to account for the largest share of the surgical dressings market in the year 2022. Owing to the significance of key growth factors such as the rising surgical procedures in the region, increasing number of advanced ambulatory surgical centers, increasing incidence of chronic diseases, increasing number of road accidents, increasing incidence of chronic wounds and ulcers, and diabetic foot ulcers, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for surgical dressings is expected to witness prosperity in the region during the forecast period 2022-2028.

The growing prevalence of diabetes is anticipated to increase market growth. For instance, according to the International Diabetes Federation's Diabetes Atlas, Tenth Edition 2021, in 2021, around 32.2 million people in the United States had diabetes. As per the same source, the number is projected to grow to 36.3 million by 2045. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases and contribute to market growth in the United States.

According to OECD 2023, nearly 3,602 total knee replacement surgeries were performed in Mexico in 2021. Also, in the same year about 980,756 cesarean section surgical procedures were done in Mexico. The increasing number of surgeries in the country will increase the demand for surgical dressings.

Further, the increasing approvals by the US FDA will also impact the market of surgical dressings in the upcoming years. For instance, in April 2023, 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing.

Also, in October 2019, Turn Therapeutics, a Los Angeles-based pharmaceutical and medical device company, received FDA clearance for its Protego antimicrobial wound dressing, which is described as a disruptive innovation to traditional petroleum-saturated gauze dressings. Thus, all the above-mentioned factors are likely to propel the growth of the surgical dressings market in the region during the forecast period from 2023-2028.

Surgical Dressings Market Key Players:

Some of the key market players operating in the surgical dressings market include: 3M, Coloplast, Molnlycke Health Care AB, Cardinal Health, Convatec Inc., Smith+Nephew, Argentum Medical, Medline Industries, LP., Advancis Medical, Medical Devices Business Services, Inc., B. Braun SE, Integra LifeSciences, Medtronic, Essity, Organogenesis Inc., Medicare, Alliqua, and others.

Recent Developmental Activities in the Surgical Dressings Market:

In October 2023, DuPont launched a new higher-adhesion, low-cyclic silicone soft skin adhesive (SSA) called DuPont Liveo MG 7-9960. The new adhesive has been developed to be used for advanced wound care dressings and adhering medical devices to the skin for extended wear time and their removal in a gentle manner.
In October 2022, Bengaluru-based Healthium Medtech launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers. Theruptor Novo is an anti-microbial and non-toxic wound dressing with technology patented in the US, India, EU, and Canada. This product works on a physical kill mechanism of attract, bind, and rupture formula - a patented technology that minimizes the development of resistant microbes and aids in the healing process.
In October 2021, Healthium Medtech launched TRUSHIELD NXT surgical wound dressing. It provides exudate and moisture management while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism.

Key Takeaways from the Surgical Dressings Market Report Study:

Market size analysis for current surgical dressings market size (2022), and market forecast for 5 years (2023-2028)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global surgical dressings market.
Various opportunities available for the other competitors in the surgical dressings market space.
What are the top-performing segments in 2022? How these segments will perform in 2028?
Which are the top-performing regions and countries in the current surgical dressings market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for surgical dressings market growth in the coming future?

Target Audience who can be benefited from this Surgical Dressings Market Report Study:

Surgical dressings product providers
Research organizations and consulting companies
Surgical dressings-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in surgical dressings
Various End-users who want to know more about the surgical dressings market and the latest technological developments in the surgical dressings market.

Frequently Asked Questions for the Surgical Dressings Market:

1. What is a surgical dressing?

A surgical dressing is a sterile pad or compress that is applied to the wound after surgery to quicken the wound's healing and elude further damage to the organ.

2. What is the market for global surgical dressings?

The global surgical dressings market is estimated to grow at a CAGR of 5.72% during the forecast period from 2023 to 2028.

3. What are the drivers for the global surgical dressings market?

The demand for surgical dressings is primarily being boosted by the increasing number of surgical procedures and accidents or trauma cases. Further, the rising number of organ transplants, increasing sports injury cases, growing elderly population, increasing incidences of chronic wounds, ulcers, diabetic ulcers, and burns, and others thereby contributing to the overall growth of the surgical dressings market during the forecast period from 2023-2028.

4. Who are the key players operating in the global surgical dressings market?

Some of the key market players operating in the surgical dressings market include 3M, Coloplast, Molnlycke Health Care AB, Cardinal Health, Convatec Inc., Smith+Nephew, Argentum Medical, Medline Industries, LP., Advancis Medical, Medical Devices Business Services, Inc., B. Braun SE, Integra LifeSciences, Medtronic, Essity, Organogenesis Inc., Medicare, Alliqua, Advanced Medical Solutions Group plc, Hollister Incorporated, deroyal industries, and others.

5. Which region has the highest share in the surgical dressings market?

North America is expected to dominate the overall surgical dressings market during the forecast period from 2023-2028. Owing to factors such as rising surgical procedures in the region, increasing number of advanced ambulatory surgical centers, increasing incidence of chronic diseases, increasing number of road accidents, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness about the biomaterial base surgical dressings among others, the North America surgical dressings market is expected to growth in coming years.

1. Surgical Dressings Market Report Introduction

2. Surgical Dressings Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Surgical Dressings Market Key Factors Analysis

4.1. Surgical Dressings Market Drivers
- 4.1.1. Increasing number of surgeries owing to the increase in the prevalence of chronic diseases
- 4.1.2. Surging cases of organ transplant
- 4.1.3. Rising number of ambulatory surgical centers across the globe
4.2. Surgical Dressings Market Restraints and Challenges
- 4.2.1. Lack of Adequate Reimbursement Policies
- 4.2.2. Stringent Regulatory Approval Process
4.3. Surgical Dressings Market Opportunities
- 4.3.1. Advances in the development of natural-based materials
- 4.3.2. Advancements in nanofibers for dressing

5. Surgical Dressings Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. Surgical Dressings Market Layout

6.1. By Product Type
- 6.1.1. Primary Dressings
  - 6.1.1.1. Film Dressings
  - 6.1.1.2. Hydrogel Dressings
  - 6.1.1.3. Hydrocolloid Dressings
  - 6.1.1.4. Foam Dressings
  - 6.1.1.5. Others
- 6.1.2. Secondary Dressings
  - 6.1.2.1. Absorbents
  - 6.1.2.2. Bandages
  - 6.1.2.3. Adhesive Tapes
  - 6.1.2.4. Protectives
  - 6.1.2.5. Others
6.2. By Application
- 6.2.1. Ulcers
- 6.2.2. Burns
- 6.2.3. Organ Transplants
- 6.2.4. Cardiovascular Diseases
- 6.2.5. Others
6.3. By End-Users
- 6.3.1. Hospitals & Clinics
- 6.3.2. Ambulatory Surgical Centers
- 6.3.3. Others
6.4. By Geography
- 6.4.1. North America Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.1.1. United States Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.1.2. Canada Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.1.3. Mexico Surgical Dressings Market Size in USD million (2020-2028)
- 6.4.2. Europe Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.1. France Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.2. Germany Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.3. United Kingdom Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.4. Italy Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.5. Spain Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.2.6. Rest of Europe Surgical Dressings Market Size in USD million (2020-2028)
- 6.4.3. Asia-Pacific Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.1. China Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.2. Japan Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.3. India Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.4. Australia Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.5. South Korea Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.3.6. Rest of Asia-Pacific Surgical Dressings Market Size in USD million (2020-2028)
- 6.4.4. Rest of the World (RoW) Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.4.1. Middle East Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.4.2. Africa Surgical Dressings Market Size in USD million (2020-2028)
  - 6.4.4.3. South America Surgical Dressings Market Size in USD million (2020-2028)

7. Surgical Dressings Market Company and Product Profiles

7.1. 3M
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Coloplast
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. Molnlycke Health Care AB
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Cardinal Health
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. Convatec Inc.
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. Smith+Nephew
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. Argentum Medical
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. Medline Industries, LP.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Advancis Medical
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Medical Devices Business Services, Inc.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. B. Braun SE
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Integra LifeSciences
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Medtronic
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. Essity
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Organogenesis Inc.
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
7.16. Medicare
- 7.16.1. Company Overview
- 7.16.2. Company Snapshot
- 7.16.3. Financial Overview
- 7.16.4. Product Listing
- 7.16.5. Entropy
7.17. Alliqua
- 7.17.1. Company Overview
- 7.17.2. Company Snapshot
- 7.17.3. Financial Overview
- 7.17.4. Product Listing
- 7.17.5. Entropy
7.18. Advanced Medical Solutions Group plc
- 7.18.1. Company Overview
- 7.18.2. Company Snapshot
- 7.18.3. Financial Overview
- 7.18.4. Product Listing
- 7.18.5. Entropy
7.19. Hollister Incorporated
- 7.19.1. Company Overview
- 7.19.2. Company Snapshot
- 7.19.3. Financial Overview
- 7.19.4. Product Listing
- 7.19.5. Entropy
7.20. deroyal industries
- 7.20.1. Company Overview
- 7.20.2. Company Snapshot
- 7.20.3. Financial Overview
- 7.20.4. Product Listing
- 7.20.5. Entropy